South Korean pricing reform suggests more flexible drug reimbursement negotiations
South Korea’s Ministry of Health and Welfare (MoHW) recently disclosed its proposal to revise the drug reimbursement and price-setting regulations…
Pricing and Market Access
Keytruda and Opdivo: a decade review
US negotiations for first round of drugs reveal $6bn in Medicare savings
Colombia’s president signs law to strengthen pharmaceutical sector
Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy
The US Biosecure Act threatens to destabilise the pharmaceutical industry
UK’s antibiotic subscription funding model – a route to market sustainability?
Ukraine: a market access review over two years of war
